New IVF study aims to boost healthy embryo rates in PCOS patients
NCT ID NCT05326087
First seen Feb 02, 2026 · Last updated May 20, 2026 · Updated 13 times
Summary
This study compares two hormone treatments (PPOS and GnRH antagonist) used during IVF in women with polycystic ovary syndrome (PCOS). The goal is to see which method leads to more genetically normal embryos. About 204 women aged 20-37 will participate, and the results may help improve IVF success rates for PCOS patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREIMPLANTATION GENETIC TESTING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.